Clinical trial
Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening
NCT07033091 is registered in ClinicalTrials.gov with The Institute of Molecular and Translational Medicine, Czech Republic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening
- Lead sponsor
- The Institute of Molecular and Translational Medicine, Czech Republic
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 1, 2025
- Completion date
- March 30, 2031
- Enrollment
- 20,000 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
oropharynx cancer